KI-Beratung Beta

Produktbild: AI in Breast Cancer Stem Cells and Proteomics

AI in Breast Cancer Stem Cells and Proteomics Precision Oncology Perspectives

Fr. 202.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

AI in Breast Cancer Stem Cells and Proteomics: Precision Oncology Perspectives explores the intersection of artificial intelligence, cancer stem cell biology, and proteomics to address the persistent challenges of relapse, metastasis, and therapy resistance in breast cancer. This book provides a translational...

Beschreibung

AI in Breast Cancer Stem Cells and Proteomics: Precision Oncology Perspectives explores the intersection of artificial intelligence, cancer stem cell biology, and proteomics to address the persistent challenges of relapse, metastasis, and therapy resistance in breast cancer. This book provides a translational framework for precision oncology through advanced computational and molecular approaches. It gives insight into the biology of breast cancer stem cells (BCSCs), their heterogeneity, and the role of proteomics in identifying biomarkers and therapeutic targets. The integration of AI enables predictive modeling, drug resistance profiling, and multi-omics data analysis, offering novel insights into personalized treatment strategies. Academics benefit from a comprehensive, interdisciplinary resource that bridges cancer biology, bioinformatics, and clinical applications.
The book equips researchers, clinicians, and students with case studies, algorithmic tools, and practical workflows to translate proteomic data into actionable medical interventions.

Portrait

Dr. Manzoor Ahmad Mir holds a Master's in Zoology from HNBG Central University and completed his Ph.D. in Immunology at Jawaharlal Nehru University, New Delhi, and CSIR-Institute of Microbial Technology, Chandigarh. His research focuses on cancer biology, combination therapy in breast cancer, and tuberculosis immunology. Dr. Mir has published over 50 high-impact research papers and book chapters. He has authored more than 15 books with international publishers of repute. He serves on the editorial boards of prestigious journals. He is a member of several scientific organizations, including the American Association of Cancer Research and the Royal British Society. He has received the TARE Fellowship and the SRFP-2019 from the Indian Science Academies. Dr. Mir teaches Cancer Biology and Immunology at the University of Kashmir, where he heads the Department of Bioresources.

Dr. Hina Qayoom is an accomplished researcher and academic currently serving as Assistant Professor in the Department of Bioresources, School of Biological Sciences, Amar Singh College, Cluster University, Jammu & Kashmir. She earned her Ph.D. in Bioresources from the University of Kashmir, specializing in Cancer Biology, where her research centered on targeting breast cancer using natural compounds with anti-cancer potential. Her doctoral work, acclaimed internationally, was selected for presentation at the prestigious ASCO 2024 Conference and published in the Journal of Clinical Oncology (Impact Factor 45.3). With over 78 peer-reviewed publications, an H-index of 18, and numerous articles in high-impact journals such as Cell Communication and Signaling, Biomedicine & Pharmacotherapy, Frontiers in Pharmacology, and Critical Reviews in Oncology/Hematology, Dr. Qayoom has made significant contributions to understanding breast cancer pathogenesis, stemness, and therapy resistance. Her work explores some of the most challenging aspects of cancer progression and therapy resistance, contributing significantly to the advancement of targeted cancer therapeutics.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

26.06.2026

Herausgeber Manzoor Ahmad Mir + weitere
Verlag Elsevier Science & Technology

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

26.06.2026

Herausgeber
Verlag Elsevier Science & Technology
Seitenzahl

338

Maße (L/B/H)

23.3/19.2/1.7 cm

Gewicht

671 g

Sprache

Englisch

ISBN

978-0-443-49109-2

EU-Ansprechpartner

Elsevier B.V.
Radarweg 29
1043 NX Amsterdam
NL
productsafety@elsevier.com

Herstelleradresse

Elsevier Science & Technology
London Wall 125
EC2Y 5AS London
GB
tradeorders@elsevier.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: AI in Breast Cancer Stem Cells and Proteomics
  • 1: Introduction to breast cancer stem cells and tumor heterogeneity
    2: Breast cancer stem cells across subtypes: Biology, challenges, and recent advances
    3: Proteomics in breast cancer: Technologies and applications
    4: Foundations of artificial intelligence in biomedical research
    5: Artificial intelligence for breast cancer stem cell characterization imaging and diagnostics
    6: Proteomic biomarkers and artificial intelligence-based predictive models
    7: Artificial intelligence for drug resistance and therapy response prediction in breast cancer stem cells
    8: Multiomics integration with artificial intelligence: From bench to bedside in breast cancer
    9: Interface between breast cancer stem cells and immunotherapy: Implications for personalized medicine with case studies
    10: Future directions: Smart oncology and personalized medicine